Immix Biopharma (IMMX) Change in Taxes (2021 - 2026)
Immix Biopharma's (IMMX) quarterly Change in Taxes came in at $725.0 in Q1 2026, up 100.04% year-on-year from $362.43 in Q1 2025, and up 105.86% quarter-over-quarter from -$12379.0 in Q4 2025.
Immix Biopharma (IMMX) Change in Taxes (2021 - 2026) Analysis & Trends
Immix Biopharma has disclosed Change in Taxes across 6 years of filings, most recently posting $725.0 for Q1 2026.
- Change in Taxes for Q1 2026 came in at $725.0, up 100.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$55202.0 (up 97.16% YoY), and the FY2025 annual result was -$2.1 million, down 311.99% from the prior year.
- Change in Taxes came in at $725.0 for Q1 2026 at Immix Biopharma, up from -$12379.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $911540.0 in Q1 2024 to a low of -$2.0 million in Q1 2025.
- The 5-year median for Change in Taxes is $29258.0 (2022), against an average of $2501.8.
- Across the five-year window, Change in Taxes surged 1199.6% in 2023 and slumped 319.8% in 2025, its largest moves.
- Immix Biopharma's Change in Taxes stood at $60949.0 in 2022, then surged by 664.45% to $465925.0 in 2023, then slumped by 51.76% to $224779.0 in 2024, then tumbled by 105.51% to -$12379.0 in 2025, then soared by 105.86% to $725.0 in 2026.
- The last three Change in Taxes figures came in at $725.0 (Q1 2026), -$12379.0 (Q4 2025), and -$21564.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | 725.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 725.00 |
| Mar 31, 2026 | 725.00 |
| Dec 31, 2025 | -12,379.00 |
| Dec 31, 2025 | -12,379.00 |
| Sep 30, 2025 | -21,564.00 |
| Sep 30, 2025 | -21,564.00 |
| Jun 30, 2025 | -21,984.00 |
| Jun 30, 2025 | -21,984.00 |
| Mar 31, 2025 | -2.00 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | 224,779.00 |
| Dec 31, 2024 | 224,779.00 |
| Sep 30, 2024 | -68,542.00 |
| Sep 30, 2024 | -68,542.00 |
| Jun 30, 2024 | -96,250.00 |
| Jun 30, 2024 | -96,250.00 |
| Mar 31, 2024 | 911,540.00 |
| Mar 31, 2024 | 911,540.00 |
| Dec 31, 2023 | 465,925.00 |
| Dec 31, 2023 | 465,925.00 |